| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | SVP &Chief Accounting Officer | SVP &Controller
2 companies
Silva Paul M serves as a SVP &Chief Accounting Officer at VRTX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 86 sells. Those positions are worth an estimated $2.2M at current prices.
Historically, Silva Paul M's trades have earned a below-average insider score of 36/100 across 4 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -9.6%.
The biggest single holding is VRTX (~$2.1M) as SVP &Chief Accounting Officer. The recent filings there lean toward selling, a net 73,056 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2026 | RAPP Rapport Therapeutics, Inc. | Director | Buy | 3,680 | $27.08 | $99,636.00 | New | - | - | |
| Mar 1, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Chief Accounting Officer | Sell | 2,782 | $211.45 | $588,255.25 | -22.0% | -0.3% | +9.7% | |
| Feb 25, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Chief Accounting Officer | Sell | 1,080 | $213.47 | $230,551.50 | -6.8% | -2.9% | +8.1% | |
| Feb 18, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Chief Accounting Officer | Sell | 4,295 | $211.83 | $909,827.62 | -20.3% | +2.0% | +9.4% | |
| Feb 11, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Chief Accounting Officer | Sell | 1,498 | $210.57 | $315,436.80 | -5.9% | +1.0% | +11.1% | |
| Aug 6, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 1,078 | $271.17 | $292,318.85 | -6.7% | - | - | |
| Aug 3, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 809 | $278.30 | $225,141.57 | -5.1% | - | - | |
| Jul 13, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 860 | $292.03 | $251,144.60 | -5.4% | - | - | |
| May 15, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sell | 151 | $284.00 | $42,884.58 | -1.0% | - | - | |
| May 6, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | SVP &Controller | Sale+OE | 1,076 | $272.74 | $293,471.78 | -6.7% | - | - |